{"id":"W4389231824","doi":"10.1182/blood-2023-188341","title":"Final Results of the Phase Ib/II Study Evaluating Enasidenib in Combination with Venetoclax in Patients with <i>IDH2</i>-Mutated Relapsed/Refractory Myeloid Malignancies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Venetoclax; Medicine; IDH2; Tolerability; Internal medicine; Phases of clinical research; Refractory (planetary science); Myeloid; Oncology; Myeloid leukemia; Gastroenterology; Adverse effect; Leukemia; Clinical trial; IDH1; Biology; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001328447,0.0008357076,0.001459646,0.0002038862,0.0003598648,0.0009203645,0.0005612321,0.0007840862,0.004739047],"category_scores_gemma":[0.0007842152,0.0003200309,0.000985581,0.0002700038,0.000466087,0.000465607,0.0002431772,0.00241804,0.0009523618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007797401,"about_ca_system_score_gemma":0.00160376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001349664,"about_ca_topic_score_gemma":0.003972811,"domain_scores_codex":[0.9997178,0.00012593,0.00001821284,0.00004697349,0.00002947774,0.00006167604],"domain_scores_gemma":[0.9994161,0.0000890084,0.00007132491,0.00004198805,0.00005651096,0.000325026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6720788,0.03757191,0.01763745,0.001368314,0.002952774,0.001023761,0.0003882166,0.006660299,0.08373504,0.0006548092,0.02449138,0.1514373],"study_design_scores_gemma":[0.4799593,0.447069,0.03532483,0.0001168789,0.001826548,0.001186805,0.0001064475,0.001629445,0.01092535,0.000576375,0.02122899,0.000049942],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9645128,0.00557206,0.001697031,0.001366977,0.0002929153,0.006143276,0.00927841,0.0002000689,0.01093645],"genre_scores_gemma":[0.9724335,0.002263589,0.003183546,0.00124001,0.0001510934,0.002558089,0.01181932,0.00005429363,0.00629655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004739047,"threshold_uncertainty_score":0.0158537,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03341786761870495,"score_gpt":0.3175984040659339,"score_spread":0.2841805364472289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}